+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Application of a validated stability-indicating chromatographic method to evaluate the reproducibility between batches of small peptides in solution



Application of a validated stability-indicating chromatographic method to evaluate the reproducibility between batches of small peptides in solution



Analytica Chimica Acta 675(1): 83-90



A stability-indicating reversed-phase high-performance liquid chromatographic method was developed and validated as per the International Conference on Harmonization (ICH) guidelines to evaluate the reproducibility of batches of synthetic peptides included in a stability program, in particular cholecystokinin (CCK-4) peptide. Both isothermal and nonisothermal approaches were used to determine stability under experimental conditions and the resulting degradation products were identified by liquid chromatography-mass spectrometry (LC-MS). The principal degradation product was the cyclic dimer, although another two products derived from it were also detected, due to the loss of one or two Phe-NH(2) residues. The dimerization follows first-order kinetics, whereas the hydrolytic cleavage implies both consecutive and in-parallel processes. The linear Arrhenius plot indicates that the degradation mechanism and kinetics do not change with temperature or the batch, but the degradation rate does depend on the batch, for example, the shelf-life at 25 degrees C was 2.54 days for batch 3, which is 13-times lower than batch 2. This variability is caused by a change in the synthesis process introduced by the manufacturer. The combination of these two elements: the analytical and stability-evaluating methods provide enough data to establish a stability-indicating profile, as required by the guideline ICH-Q6B for biotechnological/biological products.

(PDF emailed within 0-6 h: $19.90)

Accession: 051607801

Download citation: RISBibTeXText

PMID: 20708121

DOI: 10.1016/j.aca.2010.07.008



Related references

Stability of suxamethonium in pharmaceutical solution for injection by validated stability-indicating chromatographic method. Journal of Clinical Anesthesia 35(): 551-559, 2016

Application of a validated stability-indicating densitometric thin-layer chromatographic method to stress degradation studies on moxifloxacin. Analytica Chimica Acta 582(1): 75-82, 2007

Validated stability-indicating liquid chromatographic method for the determination of ribavirin in the presence of its degradation products: application to degradation kinetics. Journal of Chromatographic Science 53(4): 603-611, 2014

ICH guidance in practice: establishment of inherent stability of secnidazole and development of a validated stability-indicating high-performance liquid chromatographic assay method. Journal of Pharmaceutical and Biomedical Analysis 36(4): 769-775, 2004

A validated stability-indicating liquid chromatographic method for the determination of retapamulin in topical dosage form. Journal of Chromatographic Science 52(3): 238-245, 2014

Validated stability-indicating HPLC method for paricalcitol in pharmaceutical dosage form according to ICH guidelines: application to stability studies. Journal of Aoac International 94(2): 543-549, 2011

Validated stability-indicating liquid chromatographic method for the determination of raloxifene anti-osteoporotic agent in tablets. 2012

A validated stability-indicating liquid chromatographic method for determination of degradation impurities and diastereomers in voriconazole tablets. Scientia Pharmaceutica 80(4): 879-888, 2012

Development and application of a validated stability-indicating high-performance liquid chromatographic method using photodiode array detection for simultaneous determination of granisetron, methylparaben, propylparaben, sodium benzoate, and their main degradation products in oral pharmaceutical preparations. Journal of Aoac International 94(5): 1447-1460, 2012

Development of validated stability-indicating chromatographic method for the determination of fexofenadine hydrochloride and its related impurities in pharmaceutical tablets. Chemistry Central Journal 5(1): 76-76, 2011

Validated stability indicating liquid chromatographic determination of ebastine in pharmaceuticals after pre column derivatization: Application to tablets and content uniformity testing. Chemistry Central Journal 5: 24-24, 2011

A validated stability indicating ultra performance liquid chromatographic method for determination of impurities in Esomeprazole magnesium gastro resistant tablets. Journal of Pharmaceutical and Biomedical Analysis 57: 109-114, 2012

A validated stability indicating high performance reverse phase liquid chromatographic method for the determination of cilostazol in bulk drug substance. Drug Development and Industrial Pharmacy 33(2): 173-179, 2007

A validated and stability indicating HPLC method for analysis of diminazene aceturate and antipyrine combination in a ready injectable solution. Drug Research 63(6): 300-304, 2013

A novel validated stability indicating high performance liquid chromatographic method for estimation of degradation behavior of ciprofloxacin and tinidazole in solid oral dosage. Journal of Pharmacy & Bioallied Sciences 5(4): 298-308, 2013